The RPP STI Dx Panel genetic testing is a comprehensive diagnostic test that detects multiple sexually transmitted infections (STIs) by analyzing genetic material (DNA/RNA) from pathogens. Using advanced multiplex PCR technology, this panel identifies a broad range of common and co-occurring STIs such as Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, Ureaplasma species, and more in a single test. It offers rapid, accurate results from samples like urine, swabs, or bodily fluids, helping clinicians diagnose infections early, guide appropriate treatment, and reduce the risk of complications or transmission. It is especially useful for symptomatic and high-risk individuals.
Choosing the RPP STI Dx Panel genetic testing offers a fast, accurate, and comprehensive approach to diagnosing sexually transmitted infections. Unlike traditional methods that test for one infection at a time, this panel screens for multiple STIs simultaneously, saving time and ensuring nothing is overlooked. It detects even low levels of pathogens with high sensitivity and specificity, allowing for early diagnosis and timely treatment. This is especially important in cases where symptoms are mild, overlapping, or absent. By identifying co-infections in a single test, it improves patient care, reduces transmission risks, and supports better public health outcomes.
The RPP STI Dx Panel genetic testing is ideal for individuals who may be at risk of sexually transmitted infections or are experiencing symptoms suggestive of an STI. It is especially useful for those seeking a thorough and reliable diagnosis, even in the absence of symptoms. This test is also beneficial for sexual health screening, early detection, and treatment planning to prevent complications and transmission.
You should consider this test if:
A healthcare provider collects a sample, typically using a urine specimen, vaginal swab, urethral swab, cervical swab, or other relevant bodily fluid.
The collected sample is sent to a certified laboratory where it is prepared for analysis, including extraction of DNA or RNA from the pathogens.
The sample undergoes multiplex Polymerase Chain Reaction (PCR) to amplify specific genetic material associated with multiple STI-causing organisms.
Advanced instruments analyze the amplified genetic sequences to detect the presence of multiple STIs simultaneously with high accuracy.
A laboratory specialist reviews the results to identify which pathogens are present, including any co-infections.
A detailed report is prepared and sent to the healthcare provider, who will discuss the results with the patient and determine the next steps for treatment or management.
Our fully integrated E-Lab platform offers online test ordering, real-time tracking, and secure digital reporting bringing convenience and control to both physicians and patients across the country.
From routine blood tests to complex genetic panels, we leverage cutting-edge platforms like NGS, PCR, and AI-powered analytics for maximum accuracy and clinical relevance.
With lab facilities based in Florida, we ensure faster processing times and direct access to our expert team. You get timely results backed by responsive, local customer support.
At E-lab, we are dedicated to innovation, collaboration, and seamless growth.